Skip to content

Unmasking Concealed Arrhythmia Syndromes

Unmasking Concealed Arrhythmia Syndromes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06988189
Acronym
UCAS
Enrollment
200
Registered
2025-05-23
Start date
2024-09-09
Completion date
2026-11-30
Last updated
2025-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brugada ECG Patterns, Brugada Syndrome (BrS)

Keywords

Brugada syndrome, Ambulatory ECG, Wearable ECG, Long term continuous monitoring, AI ECG

Brief summary

This study seeks to evaluate whether using non-invasive electrocardiograph (ECG) techniques, including long term ECG monitoring with wearable ECGs, can improve the detection of concealed Brugada syndrome.

Detailed description

Application of long term continuous ECG monitoring via ECG wearables and ambulatory ECG monitors to detect manifestations of Brugada syndrome. This approach will be combined with development of an AI (artificial intelligence) enabled ECG platform to automate Brugada ECG detection and analysis. The protocol will comprise the following parts: Study A: Brugada ECG AI development. This will automate the recognition of the type 1 Brugada ECG pattern on 12 lead ECGs. Study B: Remote arrhythmia diagnostics. A prospective observational study whereby recruited participants will be fitted with a wearable ECG or cardiac monitor to undergo continuous long term ambulatory ECG monitoring. The algorithms developed in study A will be applied to long term ECG data captured in this study. Study C: Arrhythmic risk stratification using ultra-high-frequency ECG. This exploratory study will look for markers of arrhythmic risk in patients with manifest and concealed arrhythmia syndromes.

Interventions

DIAGNOSTIC_TEST12-lead ECG

12-lead ECG from a conventional ECG machine

DIAGNOSTIC_TESTContinuous long term ambulatory ECG monitoring

Continuous long term ambulatory ECG monitoring using wearable ECG or cardiac monitor

DIAGNOSTIC_TESTUltra-high-frequency ECG

Ultra-high-frequency ECG acquired using specific acquisition equipment

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults willing to take part * Able to give consent

Exclusion criteria

* Unable to give consent * Children age \< 18 years and adults \> 100 years old

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity, specificity, and area under the curve (AUC) of AI algorithm for detection of Brugada type 1 ECG pattern on 12-lead ECGs.At completion of algorithm validation, approximately 12 months after study startAssessment of performance and accuracy of AI ECG detection algorithm for type 1 Brugada ECG.
Detection rate of Brugada ECG pattern using extended-duration multi-electrode ambulatory ECG monitoring (wearable ECG) in patients with concealed Brugada syndrome.Up to 12 months from enrolmentAI ECG detection algorithm, developed in Study A, applied to full ECG recording to detect Type 1 Brugada ECG pattern.
Number of cases of Brugada or Long QT Syndrome (LQTS) detected using extended-duration multi-electrode ambulatory ECG monitoring in patients with idiopathic ventricular fibrillation (VF), after application of AI ECG detection algorithms.Up to 12 months from enrolmentAI ECG detection algorithms applied to full ECG recording to detect Type 1 Brugada ECG pattern or LQTS unmasking.

Countries

United Kingdom

Contacts

Primary ContactKeenan Saleh, MBBS
keenan.saleh10@imperial.ac.uk+442033132243
Backup ContactAhran Arnold, PhD
ahran.arnold@imperial.ac.uk+442033132243

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026